Integrative Bioinformatics and Machine Learning Identify ARG1 and S100A12 as Novel Biomarkers Associated with Innate Immune Barrier Dysfunction in Psoriasis

Abstract Background: Psoriasis is a chronic inflammatory skin disease in which the dysfunction of the innate immune cell barrier (IICB) is implicated. However, the underlying molecular mechanisms remain incompletely elucidated. This study aimed to identify and characterize IICB-related biomarkers and their regulatory networks, thereby elucidating their roles in psoriasis pathogenesis. Methods: We obtained psoriasis-related transcriptomic datasets and a list of IICB-related genes (IICB-RGs) from public databases and the literature. We performed differential expression analysis to identify DEGs, then intersected them with IICB-RGs to identify candidate genes. We then used protein-protein interaction (PPI) network analysis, machine learning, and expression validation to identify biomarkers. We constructed a nomogram to evaluate the diagnostic probability of psoriasis. We investigated the biological functions of the biomarkers through enrichment and immune microenvironment analyses. We also predicted the upstream regulatory network and screened potential therapeutic drugs targeting the biomarkers. Results: ARG1 and S100A12 were identified as biomarkers. The diagnostic nomogram incorporating these biomarkers demonstrated excellent predictive performance. Notably, both ARG1 and S100A12 were significantly enriched in key pathways, including "Toll-like receptor signaling pathway", "cytosolic DNA-sensing pathway", and "cell cycle". Immune microenvironment analysis revealed marked dysregulation of immune cells in psoriasis and showed that both biomarkers exhibited highly similar correlation patterns with differentially infiltrated immune cell populations. Moreover, hsa-miR-27a-3p was identified as a common regulator that targets both biomarkers. Drug prediction identified 21 drugs for ARG1 (e.g., Dequalinium) and 5 for S100A12 (e.g., Eptinezumab). Conclusion: This study identified ARG1 and S100A12 as pivotal IICB-related biomarkers in psoriasis, providing insights into their roles in dysregulated immune pathways and the skewed immune microenvironment. The constructed regulatory network and predicted therapeutic agents provide valuable resources for understanding psoriasis pathogenesis and exploring potential treatment strategies.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-16
DOI
https://doi.org/10.21203/rs.3.rs-10641018/v1
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Integrative Bioinformatics and Machine Learning Identify ARG1 and S100A12 as Novel Biomarkers Associated with Innate Immune Barrier Dysfunction in Psoriasis

Ahmad Taha Khalaf, Yonghong Sun, Xiaoming Liu
3 links
Research Square
Psoriasis: Treatment and Pathogenesis
preprint

Integrative Bioinformatics and Machine Learning Identify ARG1 and S100A12 as Novel Biomarkers Associated with Innate Immune Barrier Dysfunction in Psoriasis

Ahmad Taha Khalaf, Yonghong Sun, Xiaoming Liu
preprint en

Abstract

Abstract Background: Psoriasis is a chronic inflammatory skin disease in which the dysfunction of the innate immune cell barrier (IICB) is implicated. However, the underlying molecular mechanisms remain incompletely elucidated. This study aimed to identify and characterize IICB-related biomarkers and their regulatory networks, thereby elucidating their roles in psoriasis pathogenesis. Methods: We obtained psoriasis-related transcriptomic datasets and a list of IICB-related genes (IICB-RGs) from public databases and the literature. We performed differential expression analysis to identify DEGs, then intersected them with IICB-RGs to identify candidate genes. We then used protein-protein interaction (PPI) network analysis, machine learning, and expression validation to identify biomarkers. We constructed a nomogram to evaluate the diagnostic probability of psoriasis. We investigated the biological functions of the biomarkers through enrichment and immune microenvironment analyses. We also predicted the upstream regulatory network and screened potential therapeutic drugs targeting the biomarkers. Results: ARG1 and S100A12 were identified as biomarkers. The diagnostic nomogram incorporating these biomarkers demonstrated excellent predictive performance. Notably, both ARG1 and S100A12 were significantly enriched in key pathways, including "Toll-like receptor signaling pathway", "cytosolic DNA-sensing pathway", and "cell cycle". Immune microenvironment analysis revealed marked dysregulation of immune cells in psoriasis and showed that both biomarkers exhibited highly similar correlation patterns with differentially infiltrated immune cell populations. Moreover, hsa-miR-27a-3p was identified as a common regulator that targets both biomarkers. Drug prediction identified 21 drugs for ARG1 (e.g., Dequalinium) and 5 for S100A12 (e.g., Eptinezumab). Conclusion: This study identified ARG1 and S100A12 as pivotal IICB-related biomarkers in psoriasis, providing insights into their roles in dysregulated immune pathways and the skewed immune microenvironment. The constructed regulatory network and predicted therapeutic agents provide valuable resources for understanding psoriasis pathogenesis and exploring potential treatment strategies.

Research Square
Anhui University of Science and Technology (CN), Southern University of Science and Technology (CN), Soochow University (CN)
Good health and well-being
Psoriasis: Treatment and Pathogenesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon